Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 487-491

  Tsai, Alexander K ^a   Li, Na ^b   Hanson, Naomi Q ^a   Tsai, Michael Y ^a   Tang, Weihong ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Department of Biostatistics ^*  (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ALOX5AP; Coronary artery disease; FLAP; Genetics

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EUROPEAN AMERICAN; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGE OF ONSET; CARRIER PROTEINS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MIDWESTERN UNITED STATES; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 70450267553     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.018     Document Type: Article

References (21)

1. Wargovich T., Mehta J., Nichols W.W., Pepine C.J., and Conti C.R. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. J Am Coll Cardiol 6 (1985) 1047-1051
2. Spanbroek R., Grabner R., Lotzer K., et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100 3 (2003) 1238-1243
3. Dwyer J.H., Allayee H., Dwyer K.M., et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachodonic acid, and atherosclerosis. N Engl J Med 350 (2004) 29-37
4. Mehrabian M., Allayee H., Wong J., et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91 2 (2002) 120-126
5. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
6. Helgadottir A., Gretarsdottir S., St. Clair D., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population 76 (2005) 505-509
7. Zee R.Y.L., Cheng S., Hegener H.H., Erlich H.A., and Ridker P.M. Genetic variants of arachdonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 37 (2006) 2007-2011
8. Girelli D., Martinelli N., Trabetti E., et al. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study. Eur J Hum Genet 15 (2007) 959-966
9. Arnett D.K., Jacobs Jr. D.R., Luepker R.V., Blackburn H., Armstrong C., and Claas S.A. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 112 (2005) 3884-3891
10. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
11. Lake S., Lyon H., Silverman E., Weiss S., Laird N., and Schaid D. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55 (2008) 56-65
12. van der Net J.B., Versmissen J., Oosterveer D.M., et al. Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia. Atherosclerosis (2008) [Epub ahead of print]
13. Linsel-Nitchke P., Gotz A., Medack A., et al. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population. Clin Sci 115 (2008) 309-315
14. Crosslin D.R., Shah S.H., Nelson S.C., et al. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet (2009) [Epud ahead of print]
15. Kajimoto K., Shioki K., Ishida C., et al. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population. Circ J 69 (2005) 1029-1034
16. Koch W., Hoppmann P., Mueller J.C., Schomig A., and Kastrati A. No association of polymorphisms in the gene encoding 5-lipoxygense-activating protein and myocardial infarction in a large central European population. Genet Med 9 (2007) 123-129
17. Assimes T.L., Knowles J.W., Priest J.R., et al. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet 123 (2008) 399-408
18. Lemaitre R.N., Rice K., Marciante K., Bis J.C., Lumley T.S., Wiggins K.L., Smith N.L., Heckbert S.R., and Psaty B.M. Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 204 2 (2009) e58-63
19. Maznyczka A., Mangino M., Whittaker A., et al. Laukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxtgenase-activating protein gene associated with a risk of myocardial infarction. Clin Sci (Lond) 112 (2007) 411-416
20. US Census Bureau. http://factfinder.census.gov/home/saff/main.html?_lang=en. 2007.
21. Price A.L., Butler J., Patterson N., et al. Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 4 (2008) e5